SPONSORS
EHMSG gratefully acknowledges the support of the following companies and institutions
RICHEN EUROPE is the European operating branch of the RICHEN GROUP, a major international group of medical device manufacturers with a global commitment. The company specializes in developing the best solutions for patients in the field of gastroenterology. Over the years our R&D department has excelled in the design and development of high-performance safe equipment and reagents for the diagnosis of Helicobacter pylori infection. Since 2015, the Richen Group has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Platinum Sponsor.
INFAI is specialized in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes in gastroenterology, cardiovascular and inborn metabolic diseases. Helicobacter Test INFAI (HTI) is approved in centralized procedure by EMA first time in all European countries since 1997 and available for routine diagnosis of Helicobacter pylori infection. Until now more than 7.8 Mio HTI performed worldwide. In the meantime, HTI is registered as medicinal product (medical prescription) in more than 40 countries worldwide.
INFAI's laboratories in Bochum, Germany and in York, England are equipped with state-of-the-art IRMS mass spectrometer and 600 MHz NMR spectrometer which is used to investigate metabolic disorders, cardiovascular diseases and a number of other diseases. These facilities are used for internal research and product development, but are also available for collaborative and contract research. In last 10 years, a range of non-invasive, highly efficient breath tests using stable isotopes has been developed. REFEX (for patients taking PPI’s or patients with atrophic gastritis), Gastromotal (13C octanoic acid gastric emptying test) and Pancreo-Lip (13C mixed triglyceride exocrine pancreatic function test) are in preparation for approval by EMA but now available for clinical studies. INFAI is associated with a number of companies in several European countries and outside the Europe. All other developed products of INFAI you can find on our website: www.infai1.com.
Since 1997, INFAI GmbH has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Gold Sponsor.
AbelaPharm is one of Southeast Europe’s leading manufacturers of medicines and dietary supplements, and a leader in probiotics with a comprehensive probiotic portfolio. Through its unique Probiotic Excellence Center®, the company brings together science, research, innovation and advanced manufacturing. With EU GMP-certified facilities, proprietary technologies and a growing international presence, AbelaPharm develops high-quality, safe and stable products dedicated to improving health and quality of life.
Ad-Medicum and VICOR combine complementary diagnostic portfolios to provide solutions for gastroenterology, microbiology and laboratory medicine. At EHMSG 2026, our joint presentation focuses on Helicobacter pylori diagnostics, including breath testing and rapid urease testing, alongside molecular diagnostics including PCR, microbiology and other laboratory solutions. Together, we support healthcare professionals with reliable technologies, practical implementation and local expertise in Serbia and the region.
ADOC is pharmaceutical company with more than 35 years of successful experience in providing high-quality medicines and healthcare solutions. With a strong focus on patient care, innovation, and regulatory compliance. We collaborate with healthcare professionals and partners to improve access to effective therapies. The company is committed to maintaining high quality standards and contributing to better health outcomes through reliable pharmaceutical products and services.
Biocodex, a French independent family-owned pharmaceutical group founded in 1953, is committed to improving patients’ health and well- being at every stage of life, focusing on three pillars: microbiota care, women’s health, and orphan diseases. Biocodex particularly markets the probiotic strain Saccharomyces boulardii CNCM I-745, a pioneer in the probiotics category and currently the world’s #1 by value. www.biocodex.com
Esensa is a leading Serbian pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality medical devices, dietary supplements, and OTC products. As a market leader in several healthcare categories, Esensa is committed to innovation, scientific excellence, and improving patient care. Our products are trusted by healthcare professionals and consumers and are currently exported to more than 40 countries worldwide, reflecting our strong international presence and commitment to quality.
GenoScreen is a biotech company specialized in molecular microbiology and bioinformatics. Alongside expert genomics and bioinformatics services, we develop innovative molecular solutions for microbiota research and applications in healthcare, agri-food, and environmental sectors. Our portfolio also includes molecular diagnostic kits for infectious agents, enabling pathogen identification and antibiotic resistance prediction. Among them, Deeplex® HelP is a culture-free targeted deep sequencing assay for the detection of Helicobacter pylori, providing identification, antibiotic resistance prediction, and virulence profiling.
https://www.deeplex.com/deeplex-help-helicobacter-pylori-resistance-diagnostic-solution/
Hemofarm is the leader in the Serbian pharmaceutical market. Accounting for more than 60% of the total export of pharmaceutical products from the country, Hemofarm is also the largest Serbian exporter of medicines. It produces about 7 billion tablets and capsules annually. It operates on three continents and has a team of about 4,000 employees. Hemofarm is also ranked among the largest pharmaceutical manufacturers in this region and is present in 31 markets worldwide. The company is committed to constant innovation. In addition to researching and developing modern pharmaceutical products, Hemofarm pays special attention to sustainable business practices.
Logika LLC is a pharmaceutical company focused on gastrointestinal health. Operating in Serbia and Montenegro, the company collaborates with international partners, healthcare professionals and healthcare institutions to ensure access to high- quality, evidence-based products in gastroenterology. Through scientific collaboration and a commitment to patient-centered care, Logika contributes to better digestive health and improved quality of life for patients.
Founded in Turin in 2014, NanoTech Analysis began as an innovative startup in MEMS and NEMS technologies, quickly evolving into a leading player in advanced instrumentation. Since 2017, as part of Laserline, the company has accelerated its growth and strategic development. With 64 patents and multiple European awards, NTA stands at the forefront of innovation, designing cutting-edge analytical devices. Its mission is to develop a new generation of high-performance analytical instruments, tackling challenges through a completely innovative approach.
To learn more about our satellite symposium at EHMSG 2026, please click HERE
Pharmabeo is a company specializing in the distribution and servicing of medical devices in the field of in vitro diagnostics, fully compliant with SRPS EN ISO 13485:2017 and ISO 9001:2015 standards.
Our strength lies in our experienced team of certified engineers and application specialists, providing reliable technical, application, and educational support to healthcare professionals.
In partnership with leading international manufacturers, we are committed to bringing innovative, high-quality diagnostic solutions to the Serbian healthcare market and improving patient care.
Save Health Microbiome is a science-driven company dedicated to advancing human health through targeted microbiome solutions. Built on the latest research in microbiota and its systemic impact, we develop innovative, high-quality products designed to support immune function, gastrointestinal balance, and overall well-being. Our approach combines clinically validated strains, robust formulation expertise, and a deep understanding of microbiome-host interactions. We collaborate with leading scientists and healthcare professionals to ensure that products we bring to market meets the highest standards.
Join the UEG Community, Europe’s largest representation in digestive health
UEG is the multidisciplinary hub for digestive health professionals – supporting your career – whether you are a researcher, clinician, or allied health professional connecting the different fields and specialties across GI. Every October, UEG Week brings the field's brightest experts together for one of premier congresses in digestive health – your chance to learn, network, and exchange ideas beyond your own discipline.
UEG also offers all-year-round career and educational opportunities for professionals at every level, across specialties. Dive into Gutflix, UEG's platform for education content in gastroenterology (online courses, podcasts, guidelines, congress recordings and more). Stay up to date with the latest research through UEG Journal, and access Gut Guide – a practical clinical tool built in collaboration with leading European experts to support your day-to-day practice. Call to action: Learn more